使用小细胞外囊泡作为抗癌药物的新兴作用
Hyeon Su Joo1, Ju Hun Suh1, Chan Mi So1
1School of Life Science, Handong Global University, 558 Handong-ro, Buk-gu, Pohang 37554, Republic of Korea.
International journal of molecular sciences
|September 28, 2023
概括
小细胞外囊泡 (sEVs) 在癌症治疗和诊断方面表现有前途. 本综述探讨了它们作为诊断工具,药物输送系统和治疗剂的使用,包括工程策略和大规模生产.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 纳米技术纳米技术
背景情况:
- 小型细胞外囊泡 (sEVs) 越来越多地被认为是瘤学中的治疗潜力.
- 来自瘤的sEVs具有对癌症诊断和治疗有价值的生物分子.
- sEVs可以直接诱导瘤细胞死亡或修改瘤微环境以产生抗癌效应.
研究的目的:
- 审查SEV在癌症治疗和诊断中的多方面的应用.
- 为了比较sEVs的治疗疗效与当前的免疫检查点抑制剂.
- 讨论sEV工程和可扩展制造用于临床翻译的策略.
主要方法:
- 关于癌症中sEVs的当前研究的文献综述.
- 对抗免疫检查点抑制剂的sEV疗效的比较分析.
- 探索sEV工程技术和符合GMP的生产方法.
主要成果:
- sEV显示出作为诊断生物标志物和药物输送工具的潜力.
- 工程化SEV可以在临床前癌症模型中提高治疗结果.
- 可扩展的sEV制造对于临床应用至关重要.
结论:
- sEVs代表了新型癌症诊断和治疗的有希望的平台.
- 对sEV工程和制造的进一步研究对于临床转化至关重要.
- 基于sEV的策略在现有的癌症治疗中提供了潜在的进步.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


